Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A 2 activation in astrocytes and cerebral endothelial cells

Neuroscience

Volumn 199, Issue , 2011, Pages 375-385

  Askarova, S ^a   Yang, X ^a   Sheng, W ^b   Sun, G Y ^b   Lee, J C M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

A 42; CPLA 2; ERK; NADPH oxidase; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; CELL SURFACE RECEPTOR; CYTOSOLIC PHOSPHOLIPASE A2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; POLYCLONAL ANTIBODY; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ANIMAL CELL; ARTICLE; ASTROCYTE; BINDING COMPETITION; BRAIN ENDOTHELIUM CELL; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BRAIN; CELL LINE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHOLIPASES A2, CYTOSOLIC; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 83055176524     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.09.038     Document Type: Article

References (63)

1. Abramov A.Y., Duchen M.R. The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides. Philos Trans R Soc Lond B Biol Sci 2005, 360:2309-2314.
2. Arancio O., Zhang H.P., Chen X., Lin C., Trinchese F., Puzzo D., Liu S., Hegde A., Yan S.F., Stern A., Luddy J.S., Lue L.F., Walker D.G., Roher A., Buttini M., Mucke L., Li W., Schmidt A.M., Kindy M., Hyslop P.A., Stern D.M., Du Yan S.S. RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J 2004, 23:4096-4105.
3. Babior B.M. NADPH oxidase: an update. Blood 1999, 93:1464-1476.
4. Bailey T.L., Rivara C.B., Rocher A.B., Hof P.R. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res 2004, 26:573-578.
5. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-827.
6. Behl C., Holsboer F. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection]. Fortschr Neurol Psychiatr 1998, 66:113-121.
7. Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009, 118:103-113.
8. Berzin T.M., Zipser B.D., Rafii M.S., Kuo-Leblanc V., Yancopoulos G.D., Glass D.J., Fallon J.R., Stopa E.G. Agrin and microvascular damage in Alzheimer's disease. Neurobiol Aging 2000, 21:349-355.
9. Blanc E.M., Toborek M., Mark R.J., Hennig B., Mattson M.P. Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 1997, 68:1870-1881.
10. Borroni B., Akkawi N., Martini G., Colciaghi F., Prometti P., Rozzini L., Di Luca M., Lenzi G.L., Romanelli G., Caimi L., Padovani A. Microvascular damage and platelet abnormalities in early Alzheimer's disease. J Neurol Sci 2002, 203-204:189-193.
11. Buee L., Hof P.R., Delacourte A. Brain microvascular changes in Alzheimer's disease and other dementias. Ann N Y Acad Sci 1997, 826:7-24.
12. Cai H., Griendling K.K., Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003, 24:471-478.
13. Callaghan D., Bai J., Huang A., Vukic V., Xiong H., Jones A., Walker D., Leu L.F., Beach T.G., Sue L., Zhang W. P4-182: inhibition of ABCG2 transport function by amyloid-beta peptide augments cellular oxidative stress and inflammatory gene expression in cells. Alzheimers Dement 2008, 4:T724.
14. Chaney M.O., Stine W.B., Kokjohn T.A., Kuo Y.M., Esh C., Rahman A., Luehrs D.C., Schmidt A.M., Stern D., Yan S.D., Roher A.E. RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling. Biochim Biophys Acta 2005, 1741:199-205.
15. Cherny V.V., Henderson L.M., Xu W., Thomas L.L., DeCoursey T.E. Activation of NADPH oxidase-related proton and electron currents in human eosinophils by arachidonic acid. J Physiol 2001, 535:783-794.
16. Cini M., Moretti A. Studies on lipid peroxidation and protein oxidation in the aging brain. Neurobiol Aging 1995, 16:53-57.
17. de la Torre J.C. How do heart disease and stroke become risk factors for Alzheimer's disease?. Neurol Res 2006, 28:637-644.
18. Deane R., Zlokovic B.V. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 2007, 4:191-197.
19. Dineley K.T., Westerman M., Bui D., Bell K., Ashe K.H., Sweatt J.D. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal {alpha}7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci 2001, 21:4125-4133.
20. Ervin J.F., Pannell C., Szymanski M., Welsh-Bohmer K., Schmechel D.E., Hulette C.M. Vascular smooth muscle actin is reduced in alzheimer disease brain: a quantitative analysis. J Neuropathol Exp Neurol 2004, 63:735-741.
21. Farkas E., Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001, 64:575-611.
22. Giri R., Shen Y., Stins M., Du Yan S., Schmidt A.M., Stern D., Kim K.S., Zlokovic B., Kalra V.K. Beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol 2000, 279:C1772-C1781.
23. Girouard H., Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 2006, 100:328-335.
24. Heneka M.T., O'Banion M.K. Inflammatory processes in Alzheimer's disease. J Neuroimmunol 2007, 184:69-91.
25. Heumüller S., Wind S., Barbosa-Sicard E., Schmidt H.H., Busse R., Schröder K., Brandes R.P. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008, 51:211-217.
26. Hicks J.B., Lai Y., Sheng W., Yang X., Zhu D., Sun G.Y., Lee J.C. Amyloid-beta peptide induces temporal membrane biphasic changes in astrocytes through cytosolic phospholipase A2. Biochim Biophys Acta 2008, 1778:2512-2519.
27. Hofman A., Ott A., Breteler M.M., Bots M.L., Slooter A.J., van Harskamp F., van Duijn C.N., Van Broeckhoven C., Grobbee D.E. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997, 349:151-154.
28. Hsu M.J., Hsu C.Y., Chen B.C., Chen M.C., Ou G., Lin C.H. Apoptosis signal-regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis. J Neurosci 2007, 27:5719-5729.
29. Iadecola C. Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia. Cell Mol Neurobiol 2003, 23:681-689.
30. Kalaria R.N., Pax A.B. Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res 1995, 705:349-352.
31. Levy R. The role of cytosolic phospholipase A2-alfa in regulation of phagocytic functions. Biochim Biophys Acta Mol Cell Biol Lipids 2006, 1761:1323-1334.
32. Liu Q., Kkang J.H., Zheng R.L. NADPH oxidase produces reactive oxygen species and maintains survival of rat astrocytes. Cell Biochem Funct 2005, 23:93-100.
33. Lue L.F., Walker D.G., Brachova L., Beach T.G., Rogers J., Schmidt A.M., Stern D.M., Yan S.D. Involvement of microglial receptor for advanced glycation endproducts (rage) in alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol 2001, 171:29-45.
34. McDonald D.R., Bamberger M.E., Combs C.K., Landreth G.E. Beta-amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and thp1 monocytes. J Neurosci 1998, 18:4451-4460.
35. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994, 36:747-751.
36. Moses G.S., Jensen M.D., Lue L.F., Walker D.G., Sun A.Y., Simonyi A., Sun G.Y. Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflammation 2006, 3:28.
37. Murakami M., Kudo I. Phospholipase A2. J Biochem 2002, 131:285-292.
38. Origlia N., Arancio O., Domenici L., Yan S.S. MAPK, β-amyloid and synaptic dysfunction: the role of RAGE. Expert Rev Neurother 2009, 9:1635-1645.
39. Park L., Anrather J., Zhou P., Frys K., Pitstick R., Younkin S., Carlson G.A., Iadecola C. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 2005, 25:1769-1777.
40. Park L., Zhou P., Pitstick R., Capone C., Anrather J., Norris E.H., Younkin L., Younkin S., Carlson G., McEwen B.S., Iadecola C. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci U S A 2008, 105:1347-1352.
41. Riganti C., Costamagna C., Bosia A., Ghigo D. The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress. Toxicol Appl Pharmacol 2006, 212:179-187.
42. Ruitenberg A., den Heijer T., Bakker S.L., van Swieten J.C., Koudstaal P.J., Hofman A., Breteler M.M. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study. Ann Neurol 2005, 57:789-794.
43. Sasaki N., Toki S., Chowei H., Saito T., Nakano N., Hayashi Y., Takeuchi M., Makita Z. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res 2001, 888:256-262.
44. Shelat P.B., Chalimoniuk M., Wang J.H., Strosznajder J.B., Lee J.C., Sun A.Y., Simonyi A., Sun G.Y. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 2008, 106:45-55.
45. Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996, 36:83-106.
46. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A 1991, 88:10540-10543.
47. Stephenson D., Rash K., Smalstig B., Roberts E., Johnstone E., Sharp J., Panetta J., Little S., Kramer R., Clemens J. Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia 1999, 27:110-128.
48. Stephenson D.T., Lemere C.A., Selkoe D.J., Clemens J.A. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 1996, 3:51-63.
49. Sun G.Y., Horrocks L.A., Farooqui A.A. The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases. J Neurochem 2007, 103:1-16.
50. Sun G.Y., Xu J., Jensen M.D., Simonyi A. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 2004, 45:205-213.
51. Suo Z., Tan J., Placzek A., Crawford F., Fang C., Mullan M. Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res 1998, 807:110-117.
52. Takuma K., Fang F., Zhang W., Yan S., Fukuzaki E., Du H., Sosunov A., McKhann G., Funatsu Y., Nakamichi N., Nagai T., Mizoguchi H., Ibi D., Hori O., Ogawa S., Stern D.M., Yamada K., Yan S.S. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc Natl Acad Sci U S A 2009, 106:20021-20026.
53. Tan J., Town T., Suo Z., Wu Y., Song S., Kundtz A., Kroeger J., Humphrey J., Crawford F., Mullan M. Induction of CD40 on human endothelial cells by Alzheimer's beta-amyloid peptides. Brain Res Bull 1999, 50:143-148.
54. Vukic V., Callaghan D., Walker D., Lue L.F., Liu Q.Y., Couraud P.O., Romero I.A., Weksler B., Stanimirovic D.B., Zhang W. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis 2009, 34:95-106.
55. Wautier M.P., Chappey O., Corda S., Stern D.M., Schmidt A.M., Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001, 280:E685-E694.
56. Xu J., Chen S., Ku G., Ahmed S.H., Xu J., Chen H., Hsu C.Y. Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J Cereb Blood Flow Metab 2001, 21:702-710.
57. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
58. Yin K.J., Lee J.M., Chen S.D., Xu J., Hsu C.Y. Amyloid-beta induces smac release via ap-1/bim activation in cerebral endothelial cells. J Neurosci 2002, 22:9764-9770.
59. Young K.F., Pasternak S.H., Rylett R.J. Oligomeric aggregates of amyloid beta peptides:1-42 activate ERK/MAPK in SH-SY5Y cells via the alpha7 nicotinic receptor. Neurochem Int 2009, 55:796-801.
60. Zanetti M., d'Uscio L.V., Peterson T.E., Katusic Z.S., O'Brien T. Analysis of superoxide anion production in tissue. Methods Mol Med 2005, 108:65-72.
61. Zhu D., Hu C., Sheng W., Tan K.S., Haidekker M.A., Sun A.Y., Sun G.Y., Lee J.C.M. NAD(P)H oxidase-mediated reactive oxygen species production alters astrocyte membrane molecular order via phospholipase A2. Biochem J 2009, 421:201-210.
62. Zhu D., Lai Y., Shelat P.B., Hu C., Sun G.Y., Lee J.C. Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction. J Neurosci 2006, 26:11111-11119.
63. Zlokovic B.V. New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics 2008, 5:409-414.